معرفی
Lisa Gale Suter, M.D. is a Professor of Medicine in the Section of Rheumatology, Department of Internal Medicine at Yale University School of Medicine. She serves as Senior Director of Quality Measurement Programs at the Center for Outcomes Research & Evaluation (CORE), where she leads major federal contracts with the Centers for Medicare & Medicaid Services (CMS) on hospital and clinician performance measures. She is also co-chair of the Quality Measures Subcommittee of the American College of Rheumatology’s Quality of Care Committee, overseeing national measure development.
- Professor, Section of Rheumatology, Department of Internal Medicine, Yale School of Medicine
- Senior Director, Quality Measurement Program, Center for Outcomes Research & Evaluation (CORE)
- Co-Chair, Quality Measures Subcommittee, American College of Rheumatology
Dr. Suter’s research centers on quality measurement, healthcare outcomes, and technology assessment in rheumatology and musculoskeletal diseases. She has led or consulted on over 33 hospital-level outcome measures, with many implemented in federal payment programs. Her work emphasizes patient-reported outcomes, risk adjustment, and performance evaluation in complex healthcare systems.
Her recent publications reveal a strong trend in hospital quality metrics, data validation in Medicare Advantage, patient-reported outcomes in lupus, and infection screening in biologic therapy. She frequently collaborates with leading health services researchers at Yale, such as Harlan Krumholz and Arjun Venkatesh, and contributes to high-impact journals including JAMA Network Open, Health Services Research, and Arthritis Care & Research.
Dr. Suter has received significant recognition for her contributions to arthritis research:
- Named One of Most Important OA Imaging Publications in 2009 (World Congress on Osteoarthritis)
- Named Top Ten Advance in Arthritis Research for 2009 (Arthritis Foundation)
She continues to advise on national quality initiatives and lead interdisciplinary research teams focused on improving rheumatology care delivery and healthcare system performance. Her leadership in both academic medicine and national policy underscores her role as a key figure in advancing evidence-based, patient-centered care.